Treatment quality indicators for cardiovascular outcomes questioned

Treatment quality indicators measuring lipid- and albuminuria-lowering treatment status are valid quality measures, since they predict a lower risk of cardiovascular events and mortality in patients with diabetes.

The quality indicators for glucose-lowering treatment should only be used for restricted populations with elevated HbA1c levels.

Intriguingly, the tested indicators for blood pressure-lowering treatment did not predict patient outcomes.

These results from Sidorenkov et al question whether all treatment indicators are valid measures to judge quality of health care and its economics.

Read more in PLoS ONE

Diabetesbible is for health professionals